doi: 10.1111/j.1365-2710.1986.tb00854.x.
The effect of alcohol intake on the disposition of diphenhydramine in man
- PMID: 3760230
- DOI: 10.1111/j.1365-2710.1986.tb00854.x
Item in Clipboard
The effect of alcohol intake on the disposition of diphenhydramine in man
J Clin Hosp Pharm.
1986 Aug.
Abstract
The disposition of diphenhydramine (DPHA) and its principal metabolites was investigated in two subjects after i.v. and oral dosing. Based on these parameters the results of a multiple oral dose regimen were predicted and compared to the results obtained in these volunteers. During one dose interval of the multiple oral dose regimen, the volunteers indulged in social drinking. Comparison of this interval with a control period showed no differences in disposition. Alcohol therefore, would appear to have no effect on the disposition of DPHA.
Similar articles
-
Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administration.J Clin Pharmacol. 1986 Sep-Oct;26(7):529-33. doi: 10.1002/j.1552-4604.1986.tb02946.x. J Clin Pharmacol. 1986. PMID: 3760245
-
Diphenhydramine kinetics following intravenous, oral, and sublingual dimenhydrinate administration.Biopharm Drug Dispos. 1990 Apr;11(3):185-9. doi: 10.1002/bdd.2510110302. Biopharm Drug Dispos. 1990. PMID: 2328304 Clinical Trial.
-
Diphenhydramine: kinetics and psychomotor effects in elderly women.Clin Pharmacol Ther. 1982 Sep;32(3):387-91. doi: 10.1038/clpt.1982.176. Clin Pharmacol Ther. 1982. PMID: 7049503 Clinical Trial.
-
Differential effects of benzodiazepine disposition by disulfiram and ethanol.Arzneimittelforschung. 1980;30(5a):882-6. Arzneimittelforschung. 1980. PMID: 6106489
-
Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines).Clin Pharmacokinet. 1985 Nov-Dec;10(6):477-97. doi: 10.2165/00003088-198510060-00002. Clin Pharmacokinet. 1985. PMID: 2866055 Review.
Cited by
-
Lack of potentiation by cetirizine of alcohol-induced psychomotor disturbances.Eur J Clin Pharmacol. 1988;34(6):619-23. doi: 10.1007/BF00615227. Eur J Clin Pharmacol. 1988. PMID: 2971550 Clinical Trial.